ICS/LABA/LAMA wirksamer als LABA/LAMA

被引:0
|
作者
Fath R.
机构
关键词
D O I
10.1007/s15006-018-1035-6
中图分类号
学科分类号
摘要
[No abstract available]
引用
收藏
页码:69 / 69
相关论文
共 50 条
  • [1] LAMA/LABA oder LABA/ICS?
    Michael Hubert
    [J]. MMW - Fortschritte der Medizin, 2015, 157 (14) : 76 - 76
  • [2] EVELUT®: dyspnoea and symptom burden in COPD patients switching from LABA/ICS to LAMA/LABA or LAMA/LABA/ICS
    Buhl, R.
    Dreher, M.
    Mattiucci-Guehlke, M.
    Eckhardt, S.
    Taube, C.
    Vogelmeier, C.
    Buhl, R.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [3] Step up to ICS/LAMA/LABA vs switch to LAMA/LABA in patients with COPD on ICS/LABA: post hoc analysis of KRONOS
    Singh, Dave
    Bafadhel, Mona
    Bowen, Karin
    Arya, Niki
    Marshall, Jonathan
    Parikh, Himanshu
    Patel, Mehul
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [4] COMPARISON OF LAMA/LABA AND ICS/LABA AS INITIAL TREATMENT FOR COPD
    Aoyama, Junichi
    Tanaka, Yosuke
    Kosaihira, Seiji
    Okano, Tetuya
    Hino, Mitunori
    Seike, Masahiro
    Gemma, Akihiko
    [J]. RESPIROLOGY, 2019, 24 : 165 - 165
  • [5] EFFECTIVENESS OF COPD MAINTENANCE THERAPY WITH LAMA/LABA VS LAMA/LABA/ICS IN A UNITED STATES CLAIMS DATABASE
    Quint, Jennifer
    Montonen, Jukka
    He, Xintong
    de la Hoz, Alberto
    Esposito, Daina
    [J]. CHEST, 2021, 160 (04) : 1863A - 1864A
  • [6] LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis
    Rodrigo, Gustavo J.
    Price, David
    Anzueto, Antonio
    Singh, Dave
    Altman, Pablo
    Bader, Giovanni
    Patalano, Francesco
    Fogel, Robert
    Kostikas, Konstantinos
    [J]. INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2017, 12 : 907 - 922
  • [7] Extrafine triple therapy delays COPD clinically important deterioration vs ICS/LABA, LAMA, or LABA/LAMA
    Singh, Dave
    Fabbri, Leonardo M.
    Vezzoli, Stefano
    Petruzzelli, Stefano
    Papi, Alberto
    [J]. INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2019, 14 : 531 - 546
  • [8] Efficacy and Safety of High ICS Dose Fixed-Combination ICS/LABA/LAMA pMDI Compared with ICS/LABA and ICS/LABA plus LAMA in Patients with Uncontrolled Asthma: The TRIGGER Study
    Canonica, G. W.
    Virchow, J.
    Kots, M.
    Zuccaro, F.
    Carzana, E.
    Vele, A.
    Georges, G.
    Petruzzelli, S.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [9] EVELUT®: A Real-World, Observational Study Assessing Dyspnoea and Symptom Burden in COPD Patients Switched from LABA/ICS to LAMA/LABA or LAMA/LABA/ICS
    Buhl, Roland
    Dreher, Michael
    Mattiucci-Guehlke, Muriel
    Emerson-Stadler, Rachel
    Eckhardt, Sebastian
    Taube, Christian
    Vogelmeier, Claus F.
    [J]. ADVANCES IN THERAPY, 2023, 40 (07) : 3263 - 3278
  • [10] EVELUT®: A Real-World, Observational Study Assessing Dyspnoea and Symptom Burden in COPD Patients Switched from LABA/ICS to LAMA/LABA or LAMA/LABA/ICS
    Roland Buhl
    Michael Dreher
    Muriel Mattiucci-Guehlke
    Rachel Emerson-Stadler
    Sebastian Eckhardt
    Christian Taube
    Claus F. Vogelmeier
    [J]. Advances in Therapy, 2023, 40 : 3263 - 3278